Clinical Trial Update: Using "PET Response Criteria in Solid Tumors (PERCIST)" in Evaluating Response to Neoadjuvant Chemoradiotherpy for Esophageal Cancer

View source ↗

Summary

A clinical trial update exploring the use of PET Response Criteria in Solid Tumors (PERCIST) to evaluate response to neoadjuvant chemoradiotherapy in esophageal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Esophageal Cancer | Status: UNKNOWN